Reducing blood cancer risks
Study finds diabetes drug metformin may inhibit the expansion of specific mutant stem cells
Recipients of third round of Medicine by Design’s Pivotal Experiment Fund announced
Fund advances research discoveries to real benefit for human health
Disabling age-related triggers of heart disease
Research team looks to blood for answers on why aging can cause inflammation and disease
Medicine by Design-funded scientists discover a new stem cell property that could enhance life-saving blood stem cell transplants
Researchers say the findings lay groundwork that could lead to methods for expanding stem cell numbers from donated cord blood biobanks to improve availability for people with leukemia.
Cycle 2 Discussion Group: How are stemness properties of blood relevant for cell replacement therapies?
Medicine by Design is launching a new discussion group series to provide an opportunity for investigators and trainees from Cycle 2 projects to connect with each other, discuss overlapping interests, and share information about the development and implementation of new technologies and tools that could be applicable to multiple projects. Each session will feature two speakers from Cycle 2 projects, followed by a group discussion.
Mapping out the mystery of blood stem cells
Using state-of-the art sequencing technology, Medicine by Design-funded scientists have revealed how stem cells are able to generate new blood cells throughout our life, and how these same cellular mechanisms can evade chemotherapy to survive and cause relapse many years later.
Medicine by Design seeds two strategic projects: An international partnership with the University of Cambridge and a new forum that will foster collaboration between clinicians, scientists and industry
$300,000 investment will accelerate new therapies and create new research tools.
Medicine by Design announces four new team projects
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.